All Max Perutz Labs articles
-
NewsNew findings on Candida auris open up potential targets for future therapies
A study shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B.